Acoramidis for Transthyretin Amyloid Cardiomyopathy: Open-Label Extension Study Long-Term Follow-Up

Masri, A., Aras, M., Grogan, M., Jacoby, D., Maurer, M. S., Shah, S. J., Witteles, R., Wong, P. W., Ji, A. X., Du, J., Siddhanti, S., Katz, L., Sinha, U., Fox, J. C., & Judge, D. P. (2025). Acoramidis for Transthyretin Amyloid Cardiomyopathy: Open-Label Extension Study Long-Term Follow-Up. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2025.03.017
Authors:
Ahmad Masri
Mandar Aras
Martha Grogan
Daniel Jacoby
Mathew S Maurer
Sanjiv J Shah
Ronald Witteles
Paul W Wong
Alan X Ji
Jing Du
Suresh Siddhanti
Leonid Katz
Uma Sinha
Jonathan C Fox
Daniel P Judge
Affiliated Authors:
Mathew S Maurer
Author Keywords:
attr-cm
acoramidis
safety
serum ttr
Publication Type:
Article
Unique ID:
10.1016/j.cardfail.2025.03.017
PMID:
Publication Date:
Data Source:
PubMed

Record Created: